PD-1/PD-L1 Inhibitors in Cervical Cancer

Cervical cancer is one of the most common gynecological tumors, and the majority of early-stage cervical cancer patients achieve good recovery through surgical treatment and concurrent chemoradiotherapy (CCRT). However, for patients with recurrent, persistent, metastatic cervical cancer, effective t...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Front Pharmacol
Main Authors: Liu, Yuncong, Wu, Li, Tong, Ruizhan, Yang, Feiyue, Yin, Limei, Li, Mengqian, You, Liting, Xue, Jianxin, Lu, You
Format: Artigo
Jezik:Inglês
Izdano: Frontiers Media S.A. 2019
Teme:
Pharmacology
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6367228/
https://ncbi.nlm.nih.gov/pubmed/30774597
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fphar.2019.00065
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki